Engineered immune cells take aim at blistering skin disease
Disease control
Recruiting now
This study investigates whether a single infusion of a patient's own genetically modified immune cells (CD19 CAR-T cells) can safely control moderate-to-severe pemphigus vulgaris that hasn't responded to standard treatments. The therapy targets and depletes B cells, which are tho…
Phase: NA • Sponsor: Jinbo Chen • Aim: Disease control
Last updated Jul 03, 2026 19:21 UTC